Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From SEEK

HVIVO Seeks Big Pharma Partner For ‘Phase III-Ready’ Universal Flu Vaccine

Presenting Phase IIb data on FLU-v, specialized CRO hVIVO now hopes to secure a big pharma partner for Phase III studies and commercialization of the universal flu vaccine candidate. The product has been developed in a joint venture with SEEK.

Vaccines Clinical Trials

Infirst Later Than Expected With Lipid-Format Ibuprofen, But On Time In Business Plan

The London firm announces Unicough cough/cold product’s launch after reviewing clinical trial results, but holds off on a Flarin ibuprofen launch until completing a trial. “We’re very, very pleased with this, although originally we wanted to be there slightly earlier,” says CEO Manfred Scheske.

Consumer United States

Infirst Later Than Expected With Lipid-Format Ibuprofen, But On Time In Business Plan

The London firm announces Unicough cough/cold product’s launch after reviewing clinical trial results, but holds off on a Flarin ibuprofen launch until completing a trial. “We’re very, very pleased with this, although originally we wanted to be there slightly earlier,” says CEO Manfred Scheske.

Consumer United States

Infirst Expects Dr. Cocoa OTCs To Win Over Children And Parents

CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.

Consumer United States
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • PepTcell Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • SEEK
  • Senior Management
  • Gregory A Stoloff, CEO
    James S Synge, CFO
    Wilson Caparrós-Wanderley, PhD, CSO
    Stuart Robinson, Head, Bus. Dev.
  • Contact Info
  • SEEK
    Phone: (44) 02071536570
    45 Beech St.
    London, EC248AD
    UK
UsernamePublicRestriction

Register